← Back to Search

Advanced and Integrated MicroSystems (AIMS) interventions for Interdisciplinary Communication (RESET Trial)

N/A
Waitlist Available
Led By Kevin O'Leary
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patients admitted, under inpatient or observation status, to study units
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered annually in years 1 through 4
Awards & highlights

RESET Trial Summary

This trial is helping hospitals to improve care for hospitalized medical patients by implementing a set of interventions that should improve teamwork and patient outcomes.

Eligible Conditions
  • Interdisciplinary Communication
  • Interpersonal Relations
  • Adverse Events
  • Interprofessional Collaboration

RESET Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

RESET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered annually in years 1 through 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and administered annually in years 1 through 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse events
Teamwork climate using the Safety Attitudes Questionnaire (SAQ)
Secondary outcome measures
30 day readmissions
Length of stay
Patient experience

RESET Trial Design

2Treatment groups
Experimental Treatment
Group I: Phase IIExperimental Treatment1 Intervention
During Implementation Phase II, Advanced and Integrated MicroSystems (AIMS) interventions are being implemented on additional, phase II implementation units, leveraging lessons learned during phase I.
Group II: Phase IExperimental Treatment1 Intervention
Each study site has selected 1-2 units ideally suited for initial implementation of the Advanced and Integrated MicroSystems (AIMS) interventions (Phase I Implementation) and 1-2 units for later implementation of AIMS interventions (Phase II Implementation). During Implementation Phase I, AIMS interventions were implemented on the initial, phase I Implementation units. The phase II units serve as control units during phase I.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Advanced and Integrated MicroSystems (AIMS) interventions
2018
N/A
~4270

Find a Location

Who is running the clinical trial?

University of KentuckyOTHER
185 Previous Clinical Trials
222,377 Total Patients Enrolled
The University of Texas Health Science Center at San AntonioOTHER
452 Previous Clinical Trials
87,149 Total Patients Enrolled
Alamance Regional Medical CenterUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Indiana
How old are they?
18 - 65
What site did they apply to?
Indiana University Ball Memorial Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~624 spots leftby Apr 2025